Studies related to Apolipoprotein A and Chromium

Influence Of Chromium-enriched Yeast On Blood Glucose And Insulin Variables, Blood Lipids, And Markers Of Oxidative Stress In Subjects With Type 2 Diabetes Mellitus

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 36
Sex Both Genders
Age Range 45-64, 65+
Body Types Obese
Notes for this study:
In obese type II diabetic (on medication) subjects given supplemental chromium via yeast (400 micrograms daily) for 12 weeks was associated with a decrease in blood glucose relative to placebo but all other measured biomarkers were unchanged, although a reduction in insulin and weight in both groups tended to decrease further with chromium.

Lipid peroxidation (MDA) was unaffected and the antioxidant enzymes were mostly unaffected, although a decrease in glutathoine and glutathione peroxidase seen at the end of the trial in placebo was mitigated with chromium.